Latest News

Keep up to date with all our latest investments, service offerings and news items.

Click here to view our latest media kit

• November 17, 2020

  Almac Group Works to enable efficient manufacturing of remdesivir in Response to COVID-19

• November 10, 2020

  Almac Group Welcomes COVID-19 Vaccine Trial News Announced by Pfizer & BioNTech

• November 4, 2020

  Almac Group Continues HLA Scheme for Aspiring Scientists, Technologists and Engineers

• October 14, 2020

  Almac Sciences Achieves Thought Leadership Milestone

• October 7, 2020

  Almac Group Appoints Vice President of Small Molecule API

• September 30, 2020

  Almac Group Ranked Second in Belfast Telegraph’s “Businesses making the largest contribution to incomes” Table

• September 29, 2020

  Almac McKervey Award Presented for Excellence in Chemistry

• September 24, 2020

  Almac Group Launches Biologics Testing Solutions

• September 9, 2020

  Almac Clinical Technologies Named Leader in Key Industry Report

• September 9, 2020

  CBS This Morning Features Pfizer’s Phase 3 COVID-19 Vaccine Trial

• September 8, 2020

  Arran Chemical Company Continues Unique Industry – Academia Collaboration with Athlone Institute of Technology

• September 2, 2020

  Almac Group Donates a Quarter of a Million Pounds to Global Charities in Wake of COVID-19

• August 20, 2020

  Almac Group Moves to Number Five in Ulster Business Top 100 Companies List

• August 11, 2020

  Almac Clinical Services Launches Virtual Auditing Solution for Clients

• July 22, 2020

  Almac Group “CATCH”es a SFI Industry Fellowship

• July 21, 2020

  Almac Group Announces Winners of claraT Grant Programme for Academia

• June 24, 2020

  Almac Group Launches Tempod® 1000 to Improve Clinical Site Temperature Data Management

• June 18, 2020

  Almac Discovery to Present Updates on Key Oncology Programmes at the 2020 American Association for Cancer Research (AACR) Virtual Annual Meeting II

• June 12, 2020

  2018-19 Figures Show Almac Group’s Turnover Increased by £85M to £634M

• June 4, 2020

  Almac Group Welcomes Confirmation that Northern Ireland’s Pharmaceutical Industry will Maintain Regulatory Alignment with the EU Post-Brexit

• June 1, 2020

  Almac Clinical Technologies Introduces Simplify^TM, an Advanced IRT Solution Enabling Faster Clinical Trials Start-up

• May 28, 2020

  Almac Group Supports Two COVID-19 Clinical Studies in Sub-Saharan Africa

• May 14, 2020

  Almac Discovery Enters Into Licensing Agreement for the Development & Commercialisation of ALM301

• May 5, 2020

  InMed and Almac Group Developing Improved Cannabinoid Production Methods

• April 29, 2020

  Almac Discovery to Collaborate with MSD on selected DUB therapeutic targets

• April 24, 2020

  TruSight Oncology Family Grows with Liquid Biopsy and High-Throughput Assay Additions

• April 22, 2020

  Almac Group Achieves Zero Landfill Target

• April 7, 2020

  Almac Clinical Technologies announces expedited support for COVID-19 Clinical Trials

• March 31, 2020

  Self-administered pain-killer saves patient time and NHS resources in accident and emergency departments

• March 5, 2020

  Debiopharm Advances its Potent Wee1 Inhibitor into Clinical Phase

• March 3, 2020

  Call for entries for the Dr John Hinds Scholarship

• February 18, 2020

  Almac Clinical Services’ Just in Time Manufacturing Operations Pass EU Regulatory Inspection

• February 12, 2020

  Launch of innovative medical food provides a palatable new option for people diagnosed with rare metabolic disorder in the UK

• February 6, 2020

  Almac Group launches enhanced Label Approval Solution (LAS)

• January 28, 2020

  Almac Group to Host West Coast Lunch and Learn Workshop Series on Adaptable Clinical Supply Chain Strategies for Biologics

• January 22, 2020

  Almac and Pfizer celebrate success of patient-led clinical supply model in gene therapy trial

• January 10, 2020

  Northern Ireland’s STEM Excellence Celebrated

• January 8, 2020

  Galen, an Almac Company, announces Completion of Multi-Million Pound POA Pharma Acquisition

• December 12, 2019

  Almac Group and Exostar Collaborate to offer Better IRT Experience

• December 6, 2019

  Almac Group’s Comprehensive STEM Programme Wins “Innovation in Sponsorship” Award

• November 1, 2019

  Almac Group Hosts Internationally Recognised Chemistry Forum in Belfast

• October 21, 2019

  Almac Group £35 million Brexit Solution Complete

• October 7, 2019

  Almac Group Hosts Montgomery County Students for National Manufacturing Day 2019

• October 1, 2019

  Almac Group Appoints Dr Alan Lamont as VP BD & Licensing

• September 26, 2019

  Almac’s unique gene expression report enables cancer researchers to discover exciting new insights

• September 25, 2019

  Almac Pharma Services Achieves Unprecedented Global Regulatory Milestone

• September 17, 2019

  Almac Group Participates in Global Clinical Supply BlockChain Working Group

• September 16, 2019

  Almac Group Invests in Future Employees through Apprenticeship Schemes

• September 3, 2019

  Prestigious New Award Announced for Top GCSE Student

• August 13, 2019

  Almac Group to Host Clinical Trial Supply Workshop in Germany

• August 8, 2019

  Almac Group’s Position Remains Unchallenged in Ulster Business Top 100 Listings

• August 5, 2019

  Almac Group to Host EU Product Launch Workshop Series in California and Washington States

• July 31, 2019

  Almac Group Invites Biopharma Industry Members to Learn About Almac Adapt™ – Just in Time Manufacturing at Complimentary Workshop

• July 31, 2019

  Almac Diagnostic Services Launches Sample Management Service

• July 31, 2019

  Almac Diagnostic Services receives CIR (French Research Tax Credit) Accreditation

• July 26, 2019

  Almac Group Promotes High Flying STEM Careers at Airwaves Portrush

• July 8, 2019

  Arran Chemical Company forms Unique Industry – Academia Collaboration with Athlone Institute of Technology

• July 2, 2019

  Almac McKervey Award Presented for Excellence in Chemistry

• June 13, 2019

  Almac Group Launches Almac Adapt™ – a New Patient-centric Supply Solution

• June 5, 2019

  Almac Group Announces CE Mark of Diagnostic Assay to Support Turning Point Therapeutics’ Pivotal TRIDENT-1 Clinical Trial

• June 3, 2019

  Almac Group Reports Further Growth During Period of Significant Global Expansion

• May 29, 2019

  Queen’s researchers work to improve maternal health in the developing world

• May 28, 2019

  Almac Group appoints Dr Sheryl Foster as Vice President of Quality

• May 6, 2019

  Turning Point Therapeutics and Almac Diagnostic Services announce approval of an investigational device exemption for the companion diagnostic assay to the registrational TRIDENT-1 clinical study

• April 25, 2019

  Almac Group Launches TempEZ™ Site Storage Temperature Compliance Module

• April 18, 2019

  Almac Group Partner with Queen’s Researchers to pioneer potentially life-changing oesophageal cancer test

• April 15, 2019

  Almac Group Further Expands Global Analytical Services Capability

• April 8, 2019

  Almac Group Publishes Comparison Report on Automated vs Paper based Accountability & Reconciliation

• March 27, 2019

  Almac Group Launches Upgraded Version of claraT – A Unique, Software-driven Gene Expression Report

• March 26, 2019

  Almac Group Recognised with Six Life Science Leader CMO Awards

• March 20, 2019

  Almac Discovery and Elasmogen to Share Anti-ROR-1 VNAR Data at American Association of Cancer Annual Meeting

• March 18, 2019

  Almac Discovery Showcases its Deubiquitinase Drug Discovery Expertise at the American Association of Cancer Research Annual Meeting in Atlanta

• March 6, 2019

  Almac Group Announces Almac ONE™ – A Unified Clinical Trial Supply Solution

• February 25, 2019

  Almac Group Engages with Science Exchange to Promote US Small Molecule Analytical Services

• February 20, 2019

  Almac Group to host Clinical Trial Supply Lunch and Learn Workshop in San Francisco

• February 18, 2019

  Inspiring the Next Generation Almac Group Promotes STEM Careers at W5

• January 10, 2019

  W5 Opens New MED-Lab Exhibition

• January 8, 2019

  Galen Appoints Dr Dennise Broderick as Managing Director

• January 8, 2019

  Almac Group Flows into Continuous Technology

• January 7, 2019

  Stunning Science Success Celebrated

• January 2, 2019

  Almac Group Launches Second Line for High Throughput GMP Peptide Manufacturing

• December 14, 2018

  Almac Group Invites Attendees to Join Workshop in San Diego to Learn About Cold Chain Management in Clinical Trials

• November 7, 2018

  Almac Clinical Services Wins Excellence Awards at 2018 Cold Chain Global Forum

• October 25, 2018

  Inaugural Almac McKervey Award Presented for Excellence in Chemistry

• October 25, 2018

  Almac Group Receives Board of Trade Award by the United Kingdom’s Department of International Trade (DIT)

• October 24, 2018

  Almac Group Scoops Research & Development Achievement at 2018 Irish Pharma Industry Awards

• October 24, 2018

  TP Therapeutics and Almac Diagnostic Services Enter into Agreement to Develop Next-Generation Sequencing, Pan-Cancer Companion Diagnostic

• October 22, 2018

  Almac Group Announces Successful HSA Inspection of Singapore Facility

• October 19, 2018

  Almac Group Launches claraT – A Unique, Software-driven Gene Expression Report

• October 11, 2018

  Almac Group Invests in Cutting Edge Next Generation Sequencing Capabilities for Bio Pharma Clients

• October 10, 2018

  Almac Group Invests to Expand its Existing North Carolina Facility

• October 8, 2018

  Search Launched for Local Science Stars

• October 2, 2018

  Almac Group Announces Successful HPRA Inspection at its European Campus

• October 1, 2018

  Almac Group Launches Global Analytical Services Capability

• September 10, 2018

  Almac Group to host Clinical Trial Supply Lunch and Learn at North American Headquarters

• September 6, 2018

  Almac Group Marks 50 Successful Years in Craigavon

• August 27, 2018

  Almac Group Appoints New Site Head for Charnwood Campus, Loughborough, UK

• August 21, 2018

  Almac Group Appoints Jonothan Cooil as Vice President of Engineering, Facilities and Health, Safety & Environment

• August 15, 2018

  Almac Group Soars up Ulster Business Top 100 Charts

• August 6, 2018

  VNAR Based Oncology Platform in development

• July 27, 2018

  Almac Group Launches GMP High Throughput Peptide Manufacturing Service

• July 25, 2018

  Almac Clinical Technologies Releases New Podcast Series Entitled “Spotlight on IRT: Best Practices”

• July 25, 2018

  Almac Group Appoints Three Vice Presidents

• July 16, 2018

  Almac Group Invests in NMR Equipment to Enhance Existing Analytical Services Capability

• July 6, 2018

  “Portadown Gets Active” A summer scheme to support local children and end holiday hunger

• July 5, 2018

  Dr. Xavier Jacq Appointed Vice President, Biology

• June 5, 2018

  Brexit – a seamless solution

• June 4, 2018

  Almac Group turnover surpasses £500 million for first time

• May 29, 2018

  Almac Group’s Vice President of Global Business Development Appointed to British American Business Council of Greater Philadelphia (BABCPHL) Board of Directors

• May 4, 2018

  Almac Group Participates in National Take Our Daughters and Sons to Work Day

• May 1, 2018

  Almac Group Appoints David Taylor as Head of Manufacturing Operations

• April 27, 2018

  Almac Group leads key workshops at the upcoming Global Clinical Supplies Group Conference (GCSG) in Atlanta, GA

• April 23, 2018

  Latest developments in DUB inhibitors shared at Proteasome & Autophagy Congress

• April 20, 2018

  Almac Group Receives Recognition at The Irish Laboratory Awards with Laboratory Supplier of the Year Award

• April 18, 2018

  Almac Group Continues to Share Expertise as part of North America “Lunch & Learn” Seminar Series

• April 16, 2018

  Almac Group Expands US Specialised Commercial Packaging Capabilities

• April 16, 2018

  Almac Diagnostic Services Validates Illumina TruSight® Tumor 170 Cancer Mutation Panel for Prospective Testing in Clinical Trials

• April 10, 2018

  Almac Discovery to Present at AACR 2018

• April 6, 2018

  “Portadown Gets Active” — A scheme to support local children and end holiday hunger

• March 26, 2018

  Almac Group named by Deloitte as One of Ireland’s Best Managed Companies

• March 22, 2018

  Almac Group Recognised with CMO Leadership Awards

• March 22, 2018

  Almac Group Launches ‘Almac McKervey Award’ for Excellence in Organic Chemistry

• March 20, 2018

  Almac Group Partners with Indian Valley Chamber of Commerce

• March 12, 2018

  Almac Group Presents “Sir Allen McClay Award for Excellence in Chemistry”

• March 8, 2018

  US East coast storm: update

• March 2, 2018

  Storm Emma – Update

• February 28, 2018

  Almac Group Expands with Opening of £20 million Cold Chain Facility

• February 12, 2018

  Almac Diagnostic Services Partners with DNAnexus to Power Clinical Trial Assay Development

• January 29, 2018

  Research Highlighted in Nature Chemical Biology

• January 29, 2018

  Almac Group Appoints Dr Stefan Mix as Head of Biocatalysis

• January 24, 2018

  Almac Group Launches Bespoke Elemental Impurities Laboratory

• January 23, 2018

  Almac Group Implements Salesforce Service Cloud to Enhance Client and Clinical Site User Experience

• January 18, 2018

  Almac Group announces further expansion at its European Campus in Dundalk

• January 5, 2018

  Stunning Science Success Celebrated

• January 2, 2018

  Almac Group Launches Second Line for High Throughput GMP Peptide Manufacturing

• December 8, 2017

  Young people presented with accredited awards at celebration event

• December 5, 2017

  Almac Group Receives Annual Industrial Award from the Institute of Chemistry of Ireland

• December 4, 2017

  USP7 inhibitors from UbiPlexTM Platform published

• November 13, 2017

  Almac Clinical Technologies’ President & Managing Director Keynotes Life Sciences PA’s CRO & CMO Summit

• November 6, 2017

  Almac Group Enters Strategic Partnership with W5

• November 2, 2017

  Almac Group’s US Financial Controller Appointed to Irish American Business Chamber & Network (IABCN)’s Board of Directors

• November 1, 2017

  Veeva Systems Inc.: Veeva Announces Partner Approach for Best-in-Class Randomization and Trial Supply Management

• November 1, 2017

  Almac Group Announces Acquisition of BioClin Laboratories

• October 24, 2017

  Almac Group Introduces Accountability and Reconciliation Tracking

• October 23, 2017

  Queen’s University Belfast in Collaboration with Almac Group Lead Largest Study of its Kind to Transform Prostate Cancer Treatment

• October 23, 2017

  Almac Group Announces Successful MHRA Inspection at Charnwood Facilities

• October 18, 2017

  The Search is on for ‘Northern Ireland’s Top Science Students

• October 16, 2017

  Almac Pod™ – Changing the Global Dynamics of Temperature Controlled Shipping Solutions

• October 16, 2017

  Hurricane Ophelia: Almac Group Update

• October 6, 2017

  Almac Group Wins Export Achievement Award at the Pharma Industry Awards

• September 13, 2017

  Almac Group Leads Economic Growth in Pennsylvania and the U.S.

• September 4, 2017

  ALM201 Poster Presentation at 2017 ESMO Congress

• August 10, 2017

  Almac Group Announces US Workshops Targeting EU Product Launch Best Practices

• August 10, 2017

  “Portadown Gets Active” A scheme to support local children and end holiday hunger

• August 7, 2017

  High-demand IT skills being developed at innovative summer camp

• July 3, 2017

  ALM201 – Orphan Drug Designation Granted in Ovarian Cancer

• July 3, 2017

  Lismore Comprehensive Represents Northern Ireland in Young Enterprise UK final

• June 30, 2017

  Petya ransomware attack – Almac update

• June 23, 2017

  Almac Group scoops top prize at Made in the UK Awards

• June 20, 2017

  Agreement with Debiopharm to Develop Novel Wee-1 Inhibitor

• June 19, 2017

  Almac Group Recognised as a Top 50 Company for Transatlantic Operations

• June 13, 2017

  Almac Group Awarded U.S. Patents for Ground-breaking “DDRD” Assay

• June 8, 2017

  Almac Group Reports Pre-tax Profits of £27M

• May 16, 2017

  Almac Group Executives Share Expertise at Upcoming Industry Conferences

• May 8, 2017

  Wee-1 kinase patent approval granted

• April 20, 2017

  Almac Group Announces Publication of Prostate Cancer Metastatic Assay Validation

• March 15, 2017

  Almac to Exclusively Share Global Expertise in EU Product Launch Workshop

• March 14, 2017

  Almac Group Executives Share Expertise at Key Industry Events

• March 8, 2017

  Almac Diagnostic Services and EORTC Establish Collaboration for Tumour Molecular Profiling

• February 28, 2017

  Irish Ambassador to US will present distinguished awards to Beneficial Bank, Eileen McDonnell, and Sean Rooney

• February 22, 2017

  Almac Group Hosts Official Visit by British Deputy Consul General

• February 16, 2017

  Almac Diagnostic Services Appoints Dr Leeona Galligan as Vice President UK Operations

• February 14, 2017

  Therapy-resistant cancer tumours targeted with RCSI

• January 30, 2017

  Almac Group Launches Next Generation Temperature Management Software

• January 26, 2017

  Almac Group Announces Further Global Expansion as it Secures New Premises in Republic of Ireland

• January 12, 2017

  Almac Group Executive to Speak at IQPC Clinical Trial Supply Europe 2017

• January 9, 2017

  Almac Group Launches Almac Clinical University

• December 15, 2016

  Almac Group Collaborates with Exostar to Extend Clinical Trials Identity Management

• December 13, 2016

  Almac Group Appoints Professor Tom Moody as VP of Technology Development and Commercialisation

• December 12, 2016

  Almac Group Trio are Masters of Work and Study

• December 6, 2016

  Almac Group Announces Strategic Partnership with inVentiv Health

• November 28, 2016

  Almac Group Executive to Speak at CTS East Asia Conference

• November 17, 2016

  Almac Group Team Up with Irish American Business Chamber & Network for Life Sciences Forum

• November 14, 2016

  Almac Group Expands Commercial Capabilities to Meet Industry Demand for Paediatric Formulations

• November 10, 2016

  Almac Group Announce £27 million Global Expansion

• October 28, 2016

  Almac Group Appoints Dr. Victor Diaz Perez as Head of Physical Sciences

• October 18, 2016

  Almac Group’s Temperature Management Software Solution Receives Innovation Award

• October 14, 2016

  Almac Group Wins Prestigious Research and Development Award

• October 10, 2016

  Almac Group Discover an Exciting Link between its Immune Response Assay and Checkpoint Inhibitor Based Therapy

• October 4, 2016

  Almac Diagnostic Services Partner with ArcherDX

• September 20, 2016

  Almac Group Celebrates 20 Years in North America with $5.2 million Expansion Creation of 79 Additional Jobs in North Carolina

• August 8, 2016

  Almac Publish Second Validation of Stage II Colon Cancer Recurrence Assay in the Journal of Clinical Oncology

• August 2, 2016

  Almac Group’s Integrated Development to Commercialisation Services Support Amicus Therapeutics’ First Commercial Orphan Drug Product

• July 14, 2016

  Almac Group’s Rapid Launch Services Support U.S. Approval of Intercept Pharmaceutical’s First Commercial Orphan Drug Product

• June 14, 2016

  Successful Inspection by FDA of Almac Clinical Services North Carolina Facility

• June 8, 2016

  Almac Diagnostic Services Expand Companion Diagnostic Development Service Offering with NanoString Barcoding Technology

• June 2, 2016

  Almac Appoints New Vice President of Corporate Marketing

• May 30, 2016

  Diseases of the eye explored with McClay Foundation and UU

• May 23, 2016

  Almac to partner with ZYMtronix to deploy its universal enzyme immobilisation platform

• May 9, 2016

  The Almac Pod™ – Changing the Dynamics of Temperature Controlled Shipping Solutions

• April 25, 2016

  Almac Clinical Technologies Announces Participation in the Avoca Diligent Prequalification Platform

• April 25, 2016

  Almac Group Launches US Serialisation Solution in Partnership with Optel Vision

• March 23, 2016

  Almac Wins Three CMO Leadership Awards

• March 8, 2016

  Almac Group Opens Additional Companion Diagnostic Laboratory in Durham NC USA

• March 2, 2016

  Almac Group Win Irish American Business Chamber Award in USA

• January 25, 2016

  NEW Fluorescence Lifetime Platform Unveiled at SLAS

• November 12, 2015

  Almac Group to Collaborate with Illumina on Next-Generation Sequencing Based Companion Diagnostic Development

• November 9, 2015

  Almac Group announces significant expansion in pharmaceutical development capacity

• November 3, 2015

  Almac Acquires Arran Chemical Company and Expands Biocatalysis Services

• October 12, 2015

  Industry’s Newest Generation IRT Fuels Growth of Almac Group’s Business

• October 7, 2015

  Almac Group Addresses Industry Demand for Multiparticulate Drug Products with Scalable Fluid Bed and Encapsulation Technologies

• October 5, 2015

  European Patent Protection for ALM201 Secured

• September 9, 2015

  Almac Group’s Integrated CMC Services Support US Approval of Wellstat Therapeutics’ First Commercial Orphan Drug Product

• September 7, 2015

  Almac Group’s Asia Pacific Headquarters Receives Official Health Science Authority (HSA) Accreditation

• September 7, 2015

  Almac Group Expands Clinical Trial ‘Direct to Patient’ Service throughout Europe

• July 10, 2015

  Almac Group Expands Asia Pacific Presence with New Regional Headquarters and Clinical Trial Supply Facility in Singapore

• July 10, 2015

  Almac Group Appoints New Vice President of Global Business Development

• July 10, 2015

  Almac Group Appoints Dr. John Robson as VP Quality Operations

• July 10, 2015

  Almac Group Announce Companion Diagnostic Partnerships with OncoMed

• July 10, 2015

  Ubiquitin Specific Protease Collaboration with Genentech

• July 10, 2015

  Almac Group Named UK Trade & Investment Winner in Final of the European Business Awards 2014/5

• March 3, 2015

  Almac Group Appoints Dr. Shirin Khambata Ford as VP Product Development

• February 5, 2015

  Almac Group Drives Biocatalysis Leadership with a Further $7M Investment

• February 5, 2015

  Almac Appoints VP Quality and Regulatory Affairs

• December 8, 2014

  Almac Crowned overall Ulster Bank Business Achiever

• November 26, 2014

  Almac raises £9,000 for ovarian cancer charity in memory of employee

• November 5, 2014

  Almac continues winning streak at Irish Pharma Industry Awards 2014

• October 21, 2014

  Almac’s PATHWAY™ Points Students in Right Direction for STEM Careers

• October 20, 2014

  Almac Introduce Flexible Clinical Trial Direct to Patient Solution

• July 10, 2014

  PA Governor Tom Corbett Praises Almac during Visit

• June 5, 2014

  Almac Launches Recruitment Drive to Fill up to 20 New Positions

• June 2, 2014

  Almac validates novel test for Ovarian Cancer patients

• May 27, 2014

  Almac sees profits increase by 30% as company enjoys record year

• May 1, 2014

  Almac flies high at Aer Lingus Viscount Awards

• March 28, 2014

  Almac Achieves Double Success at Business Award Ceremony

• March 11, 2014

  Almac Expands Asia Pacific Operations, Establishes Regional Operations Center in Singapore

• January 28, 2014

  Data Presented Supporting Almac Developed Colon Signature as a Significant Predictor of Risk of Recurrence in Stage II Colon Cancer

• January 21, 2014

  Almac publishes breast cancer chemotherapy response assay in the Journal of the National Cancer Institute

• December 10, 2013

  Almac wins Laboratory Team of the Year at The Irish Laboratory Awards 2013

• November 26, 2013

  Genomic Health and Almac Group Enter Exclusive In-Licensing Agreement to Develop and Commercialize Anthracycline Chemotherapy Benefit Test for High Risk Breast Cancer

• November 18, 2013

  Almac Further Enhance 3rd Party Logistics Commercial Support Services for Niche / Orphan Drugs

• November 13, 2013

  Almac’s Strengthened Facilities Accommodates Demand of Late Stage API Manufacture

• November 5, 2013

  Almac Increase Global Stability Storage Capacity

• October 29, 2013

  Richard Segiel, Jr. Joins Almac as Vice President of US Business Development

• October 23, 2013

  Almac invests to accelerate formulation development services

• October 22, 2013

  Almac expands US & UK commercial facilities

• October 22, 2013

  Novozymes Biopharma announces collaboration with Almac in Drug Manufacture, Half Life Extension and Targeting Technologies

• October 7, 2013

  Almac Launches New [14C]-labelled ADCs Service Offering

• September 23, 2013

  Almac Launches SupplyTraQ™ Technology Solution to Streamline Clinical Trial Supply Administration

• September 19, 2013

  Almac Launches Reusable Shipper Option for Temperature-Controlled Distribution

• September 10, 2013

  Almac Offering TruSight Tumor Profiling Next-Generation Sequencing Service

• September 4, 2013

  £13m Investment Cancer Research Initiatives with QUB

• July 31, 2013

  Almac Receives Appreciation Award from Otsuka America Pharmaceutical, Inc.

• July 2, 2013

  Almac Introduce Contained Drug Handling and Bottling Capabilities in EU and US Clinical Services Sites

• June 11, 2013

  ALMAC ANNOUNCES FURTHER EXPANSION AND 229 NEW JOBS

• June 7, 2013

  Almac Employees Reward Macmillan Belfast, Mindwise Lurgan and Craigavon’s Neonatal Unit in Annual Charity of Choice Survey

• May 15, 2013

  Almac secures new metagenomics and enzyme discovery programme with UCL

• April 26, 2013

  You don’t need to wear a lab coat to work at Almac!

• February 20, 2013

  Almac Receives FDA Inspection Approval

• February 18, 2013

  Almac and DSM Collaboration Agreement in Biocatalysis Continues with Success

• February 13, 2013

  Almac to deliver insight into Supply Chain Management at Clinical Trial Supply Europe Event

• February 6, 2013

  Almac launches US commercial packaging operations with successful FDA inspection and new client partnership

• January 21, 2013

  Almac Successfully Completes Knowledge Transfer Partnership with Queens University with Highest Accolade

• January 14, 2013

  Almac Doubles Drug Product Development Capacity with a New Non-GMP Facility

• January 7, 2013

  Almac and TTP Labtech form alliance in fluorescence lifetime technology

• December 12, 2012

  Charlie Morris Appointed to Almac’s Clinical Technologies Executive Team

• November 16, 2012

  Almac’s Early Christmas Present to Local Cancer Charity

• November 7, 2012

  Recycling works: Almac’s new environment initiative saves £72,000 per year

• October 10, 2012

  Almac increase early phase ‘hit to lead’ chances with Pre-Clinical Screening Packages

• October 9, 2012

  Almac Concludes Commercial API Manufacturing Facility Expansion Plans

• October 8, 2012

  Almac and DSM Sign Collaboration Agreement in Biocatalysis

• October 3, 2012

  Almac expands UK commercial capacity with the acquisition of new blistering technology

• September 26, 2012

  Successful MHRA Inspection of Almac’s Clinical Services UK Facility

• September 17, 2012

  Almac Launches New Histone Reagents Catalogue and Custom Synthesis Service

• August 21, 2012

  Almac announces launch of Next Generation Sequencing service for personalised medicine

• August 8, 2012

  Almac Streamline Temperature Sensitive Clinical Supplies with Enhanced Service Offering

• July 18, 2012

  US Consul General applauds Almac’s economic contribution to the US pharmaceuticals market

• July 2, 2012

  Almac launches mobile website in response to large mobile user base

• June 13, 2012

  Almac Introduces Qualified Person Facilitation Program

• June 11, 2012

  Almac and VTU Technology form collaboration to provide customers with high yielding, fast-track generation of site-specific modified products

• May 14, 2012

  Almac Adds High-Speed Clinical Trial Blistering Equipment at US HQ

• May 1, 2012

  Almac installs Uhlmann Blister Line in new US Commercial Packaging Facility

• April 26, 2012

  Almac Rewarded for Excellence in Technology

• April 4, 2012

  Almac reports progress in Clinical Technologies Lean Six Sigma Efforts

• March 29, 2012

  Almac and Affymetrix Announce a Global Distribution Agreement for Almac’s Xcel™ Array

• March 15, 2012

  Almac’s Clinical Trial Workshop Series to return in 2012

• March 15, 2012

  Almac and SRC to boost training for science careers

• March 12, 2012

  Almac adds aXcess™ to its suite of services to complement clinical packaging and distribution bundle

• March 7, 2012

  Almac expands in US with addition of Commercial Packaging facility in Audubon

• February 28, 2012

  Almac Boosts Capacity and Productivity with Acquisition of New Encapsulation Equipment

• February 13, 2012

  selectAZyme™ grows into metabolite synthesis

• February 9, 2012

  One Year On…Almac Doubles Analytical Capacity in US Headquarters

• February 1, 2012

  Almac announce launch of Next Generation Sequencing (NGS) Data Analysis Services

• January 23, 2012

  Almac Celebrates MHRA Audit Successes

• January 17, 2012

  MGB Biopharma and Almac Collaborate on Contract Manufacturing Project

• January 11, 2012

  Almac strengthens Board with appointment of new Financial Director

• January 9, 2012

  New building will help Almac serve customers from Argentina to Zimbabwe

• November 30, 2011

  Almac’s Diagnostic Laboratory Receives Accreditation from College of American Pathologists

• November 29, 2011

  Almac extends helping hand to local charities

• November 28, 2011

  Almac Shines At Awards Ceremonies

• November 21, 2011

  Almac Responds to Alexion’s Request for Rapid Packaging and Distribution During Public Health Crisis in Germany

• November 17, 2011

  Co Tyrone woman is Almac’s 2,000th UK employee

• November 8, 2011

  Almac publishes Stage II colon cancer recurrence signature in the Journal of Clinical Oncology

• October 25, 2011

  Almac’s rapidd continuing to accelerate early stage development 2 years on

• October 24, 2011

  Almac Invests in New Commercial API Manufacturing

• October 21, 2011

  Almac Invests £1M in Dedicated Mass Spectrometry Laboratory

• October 20, 2011

  Almac Announces Expansion of Pharmaceutical Development Facilities

• October 5, 2011

  Almac and Greenphire Form Alliance to Deliver Direct-to-Patient Stipend Payments Through IXRS®

• September 23, 2011

  Almac flies the flag for European Day of Languages

• September 8, 2011

  Almac takes a clinical approach – Almac CEO Alan Armstrong talks about the firm’s continuing expansion

• September 7, 2011

  Almac-Queen’s cancer expert to lead £4.4m collaboration

• July 19, 2011

  Almac wins ‘The American Society for Quality’ Award in Philadelphia

• July 4, 2011

  Almac to perform the analytic phase of AclarusDx™ for Exonhit

• June 30, 2011

  Almac Expands Global Coverage by Adding Depots for Clinical Trial Supply Distribution to the Asia Pacific Region

• June 17, 2011

  Almac to Feature New Enhancements to its Integrated Supply Chain Management and Patient Compliance Services at the Annual DIA Meeting in Chicago

• May 31, 2011

  Almac data to be presented at annual ASCO meeting

• May 20, 2011

  Almac celebrate official opening of North American HQ with former US. Senator George Mitchell

• May 11, 2011

  Almac to host inaugural European Product Launch workshop for US Biopharmaceutical Companies

• May 6, 2011

  Todd Kole Appointed to Almac’s Clinical Technologies Executive Team

• May 4, 2011

  Almac Introduces selectAZymeTM

• April 13, 2011

  Almac wins 2011 Northern Ireland Business of the year accolade

• April 7, 2011

  Northgate Managed Services Delivers Seamless Transfer to Almac’s New US HQ

• March 30, 2011

  Almac open CLIA lab for biomarker clinical trials

• March 28, 2011

  BioFocus and Almac collaborate to offer fluorescent lifetime assays

• March 25, 2011

  Almac announces expansion to its commercial facility with the addition of increased storage capacity for biologic products

• March 23, 2011

  Almac to Demonstrate New Patient Management Services at the Euro DIA and Partnerships in Clinical Trials Conferences

• March 16, 2011

  The A to ZED of Automated Walleting for clinical trial supply

• March 1, 2011

  Live Webinar March 28th: An Integrated Approach to Biomarker Discovery

• February 28, 2011

  Almacs New Headquarters Takes Control of Scheduled I-V Substances Capabilities

• February 17, 2011

  Almac announce Launch of Bioinformatics Consultancy

• February 14, 2011

  Graham Nicholls of Almac Group to Speak on Adaptive Trial Designs and Clinical Supplies at CTS Europe Conference

• February 7, 2011

  Almac Opens Analytical Labs in New US Headquarters

• January 19, 2011

  Distribution Heats Up as Almac Continues its Transition to New North American Headquarters

• December 16, 2010

  Almac wins News Flow of the Year Category at the Genesis 2010 Awards

• November 26, 2010

  Almac adds Late Stage Customisation Suite to assist Orphan Drug / Niche Product Launches into Europe

• November 23, 2010

  Almac discusses its investment in biocatalysis lauding cost and environmental benefits on OutsourcingPharma.com

• November 19, 2010

  Almac and the Royal Society of Chemistry host a workshop on the use of analytical techniques to control and monitor solid form

• November 10, 2010

  Almacs Clinical Technologies Business Unit Again Receives `Best Places to Work in PA 2010′ Award

• October 18, 2010

  Almac has Successful MHRA Inspection at its Clinical Services UK Site

• October 13, 2010

  Almac Successfully Moves its Clinical Technologies Business Unit into New North American Headquarters

• October 7, 2010

  Almac continues biocatalysis business growth with a further $4m R&D investment

• October 4, 2010

  Almac ‘Event in the Tent’ raises £14,500 for Charities

• October 4, 2010

  Almacs North American Headquarters Opens Its Doors for Audits

• September 21, 2010

  Almacs Clinical Technologies Division undergoes successful joint GCP-GMP MHRA Inspection

• September 20, 2010

  Almac One Step Closer to Completion of U.S. Headquarters Buildings

• September 3, 2010

  View our Client Message Regarding New North American Headquarters

• August 26, 2010

  Almac Discusses New Biomarker Service on OutsourcingPharma.com

• August 2, 2010

  Almac launch Biomarkers for biopharma

• July 9, 2010

  Bill Kane Joins Almac as Director of Quality Assurance and Regulatory Compliance

• July 7, 2010

  Almac supports Queens University “oncology hub” with new McClay library

• June 28, 2010

  Almac Announces Collaboration with Aeterna Zentaris to Develop Therapy and Companion Diagnostic in Cancer

• June 23, 2010

  Special Recognition Accolade posthumously awarded to Sir Allen McClay, Founder of Almac

• June 21, 2010

  Almac’s US Headquarters will Address Capacity Demand for Clinical Supplies

• June 14, 2010

  Almac completes £2 million client sponsored investment expanding commercial sacheting capacity

• June 11, 2010

  Almac to feature Expert Speakers at Upcoming DIA Annual Meeting

• June 9, 2010

  Almac Announces Launch of IXRS® 2.0 Next Generation Clinical Technology

• June 3, 2010

  Almac Launch Xcel Array – the Optimum Platform for Biomarker Discovery

• May 26, 2010

  Almac wins UK Great Place to Work award

• May 12, 2010

  Almac and University College Cork announce launch of academic/industrial collaboration

• May 5, 2010

  Almac’s North Carolina Facility Continues Growth in Academically based Clinical Trials

• April 29, 2010

  Almac extends Site-specific PEGylation Technology to single domain antibodies

• April 22, 2010

  Almac Announces Environmentally-Friendly Features

• April 21, 2010

  Graham Nicholls Joins Almac as Director of Biostatistics

• April 19, 2010

  Almac completes its expansion plan to Pharma Services facilities

• April 15, 2010

  Almac Group Finds Pharmony With New Website

• April 12, 2010

  Almac partners with Merck KGaA and the MRC to assess markers of response to Cetuximab therapy

• April 8, 2010

  Almac Clinical Technologies Releases Almac Interactive Reporting for IXRS

• April 7, 2010

  Almac wins Excellence in Innovation Category at Tenth Annual Belfast Telegraph / BMI Northern Ireland Business Awards – Read more.

• April 7, 2010

  New FLEXYTE® Protease Assays Enable Information-rich Output, Miniaturization and Multiplexing

• April 1, 2010

  Almac to Improve Label Approval Process in Clinical Trials

• March 17, 2010

  Almac and Queens University Belfast showcase Northern Irish ‘oncology hub’ to senior Washington DC delegates

• March 8, 2010

  Almac wins prestigious Aer Lingus Viscount Award for Overall Excellence

• March 5, 2010

  Successful Inspection by FDA of Almac Clinical Services North Carolina Facility

• February 26, 2010

  Almac Expands Radiolabelling Facilities to Include 14C API and IMP Supply

• February 17, 2010

  Almac Launches New STEMS System to Transform Temperature Controlled Shipment Monitoring in Clinical Trials

• February 10, 2010

  Almac adds Xcelodose® 600S Precision Powder Micro-dosing System to its Product Development Capabilities

• January 18, 2010

  Almac Announces that AstraZeneca is to Undertake Evaluation FLEXYTE Protein Kinase Assays

• January 13, 2010

  Statement on the Sad Death of Sir Allen McClay

• December 7, 2009

  Almac Clinical Technologies Announces Patient-Reported-Outcomes Partnership with FACIT.org

• December 1, 2009

  Bioinformatics Expansion Heralds Further Growth for Almac

• November 16, 2009

  Almac Doubles Capacity at North Carolina Facility

• November 10, 2009

  Almac to Speak at Upcoming CDISC Interchange with Technology Partners

• November 2, 2009

  Almac Launches Unique Site-specific PEGylation Technology at BIO Europe

• October 15, 2009

  Almac Announce Potent Containment Capabilities

• October 14, 2009

  Almac Extends Commercial Support Services to add Third Party Logistics “3PL”

• October 14, 2009

  “rapidd” Accelerating Early Stage Development, Minimising Cash Burn

• October 13, 2009

  US Labs will Extend Analytical and Solid State Support

• October 13, 2009

  Almac and Edinburgh Instruments launch of FLEXYTE fluorescence lifetime assays at MipTec

• October 9, 2009

  Almac staff raise £9,000 for local charities

• October 1, 2009

  Almac Clinical Technologies Named One of the ‘Best Places to Work in PA 2009’

• September 29, 2009

  Almac Secures Room to Grow; Plans Expected to Lead to 500 Jobs

• September 15, 2009

  Almac and Lilly Partner on Companion Diagnostic Development

• September 2, 2009

  Establishment of McClay Foundation Marks New Era for Northern Ireland

• July 28, 2009

  UM Breast Cancer Researchers partner with Almac to win prestigious Department of Defense Grant

• July 21, 2009

  MHRA Grants Almac IMP License for its Radiolabelling Service

• July 15, 2009

  Almac Group Continues Aggressive Hiring Campaign in PA to Meet Growing Demand from Pharma and Biotech Customers

• July 9, 2009

  Official opening of Almac Diagnostic Services headquarters

• June 30, 2009

  Almac Completes Phase 1 of its Expansion Plan to Pharma Services Facilities

• June 17, 2009

  Almac to Showcase Integrated Clinical Trial Solutions at 45th Annual DIA Meeting

• June 2, 2009

  Almac and Middlebrook Pharmaceuticals discuss their successful partnership in Tablets and Capsules

• May 18, 2009

  Almac Announces Collaboration with Pfizer and the PETACC3 Translational Research Working Party

• May 15, 2009

  Almac Event Proves Engineers Make It Happen

• April 29, 2009

  Dr Tanney Discusses Challenges Faced in Fine Tuning Sample Preparation Techniques

• April 27, 2009

  Minister Praises Craigavon Life Sciences Firm’s Commitment to R&D

• April 23, 2009

  Almac Launches Biocatalyst Kits

• April 23, 2009

  Almac and PHT Announce Formal Alliance to Improve Clinical Trial Data Quality

• April 6, 2009

  Almac – `Business of the Year Award is Company Milestone’

• April 6, 2009

  Almac Group Uses HP Technology to Bring New Drugs to Market Faster

• March 19, 2009

  Almac Showcases ePRO Technology at 21st DIA EuroMeeting

• March 18, 2009

  Almac Tops Off New North American Headquarters

• March 10, 2009

  Almac Collect Top Recognition for New Ovarian Cancer Research Product

• March 5, 2009

  Almac Win “Exporter of the Year” in Economic Awards

• February 24, 2009

  Almac Completes First Paperless Client Audit

• February 13, 2009

  Almac Continues Global Expansion of Clinical Supply Services with Huge Facility for Specialist Storage

• February 5, 2009

  Almac Jobs Boost for Northern Ireland

• February 5, 2009

  Almac Pharma Services Retained by MiddleBrook Pharmaceuticals to Produce Physician Samples of MOXATAG

• January 29, 2009

  Almac Promotes Biocatalysis and Radiolabeling

• January 29, 2009

  Almac Launches Solid State Services

• January 26, 2009

  Intelligroup Secures Multi-Million Dollar COSMOS Implementation with Almac Clinical Services

• January 19, 2009

  Key Almac division celebrates 20 years of growth

• January 8, 2009

  Almac Selects NuGEN Ovation® Systems to Broaden Gene Expression

• January 7, 2009

  Almac Clinical Technologies Expands Yardley, PA Headquarters

• January 6, 2009

  Almac Growth Continues Into 2009

• December 1, 2008

  Almac Clinical Services milestone achievement as full GMP compliance achieved across global sites

• November 27, 2008

  Almac addresses leading cancer specialists at All-Ireland conference

• October 10, 2008

  Almac Clinical Services Craigavon Facility Achieves Successful Inspection by MHRA

• October 8, 2008

  Almac Group Staff Raise £7,000 for Local Charities

• September 29, 2008

  Successful inspection by MHRA of Almac Clinical Services’ Pennsylvanian facility

• September 18, 2008

  “Real potential of clinical technologies yet to be realized” says Almac

• September 16, 2008

  Almac Diagnostic Services Launches Ovarian Cancer Research Tool

• August 11, 2008

  Almac Donate $50,000 to Harleysville Area Emergency Medical Services

• July 31, 2008

  Almac Announce World’s Largest Gene Expression Study To Develop Prognostic Test for Early Non Small Cell Lung Cancer

• July 24, 2008

  Governor Rendell and Sir Allen McClay break ground at site of new Almac North American headquarters

• July 2, 2008

  Almac Testers Receive ISTQB Software Testing Certification

• June 27, 2008

  Almac Diagnostic Services Join Personalized Medicine Coalition

• June 10, 2008

  Almac Group Launches Oncology Discovery Arm

• May 20, 2008

  Almac Clinical Technologies signs contracts for a number of large, complex Clinical Trials

• May 12, 2008

  WebEZ™ reaches a key milestone

• May 8, 2008

  Almac Diagnostic Services in new deal to provide unique process to extract genetic information from Clinical Trial samples

• March 31, 2008

  Almac Showcases Fully Integrated Suite of e-technologies at Partnerships with CROs and EDC & Beyond

• March 20, 2008

  Almac Pharma Services Expands it Commercial Support Capability

• March 17, 2008

  Almac appoints new VP Commercial Operations for Pharma Services

• February 26, 2008

  Almac Inks 15-Year Deal with Affy to Secure Rights to Develop and Sell Array-Based Dxs

• February 23, 2008

  The Power of Communication

• February 21, 2008

  Almac Diagnostic Services Extends Agreement with Affymetrix

• February 19, 2008

  Almac Expands Express Suite at DIA EuroMeeting

• January 29, 2008

  Largest Ever Clinical Trials Cargo Shipped from Northern Ireland

• January 28, 2008

  Almac: more US connections

• January 11, 2008

  Almac & Merck to Present Adaptive Case Study at Upcoming Conference

• December 18, 2007

  Almac wins top award at Tech Idol Showcase

• December 5, 2007

  Almac Sciences: a global supply chain approach

• December 5, 2007

  Almac Sciences: “First in man” approach to peptides

• November 23, 2007

  Almac at the center of industry thinking

• November 20, 2007

  BRCA1 Mutations Influence Cancer Cells’ Response to Drugs

• October 23, 2007

  Almac to Build New US American Headquarters

• October 16, 2007

  Almac Teams up with the Leukemia and Lymphoma Society

• October 15, 2007

  Northern Ireland First Minister Commends Almac as a World Class Pharmaceutical Organisation

• October 8, 2007

  Almac Clinical Technologies Hires New Director in San Francisco Office

• September 11, 2007

  Recent Survey Results Praise Customer Service

• August 28, 2007

  Almac’s Web Drug Reconciliation tool named finalist in GCPj awards

• August 8, 2007

  Top of the Class for Almac Fundraisers

• August 8, 2007

  Almac Diagnostic Services Announces Pioneering Genetic Research on Ductal Carcinoma In Situ (DCIS) Using Breast Cancer DSA™ Research Tool

• August 6, 2007

  Sir Allen Interview Features in Belfast Telegraph’s “The Monday Interview”

• July 31, 2007

  Almac Clinical Technologies Launches IXR Express: A new way for clients to accelerate the clinical trial process

• July 25, 2007

  Almac present on Investigational Medicinal Products to leading Industry body

• July 3, 2007

  Almac Clinical Services Feature in “The Big Question”

• June 25, 2007

  Almac Group Highly Commended at NI Workplace and Employment Awards

• June 20, 2007

  Almac Clinical Services to present at FDA Symposium at Harvard University.

• May 31, 2007

  Almac Diagnostic Services Attends Pre-ide Meeting With FDA for Colorectal Cancer Diagnostic Derived from FFPE Tissue Craigavon, Northern Ireland, 28 May 2007

• May 31, 2007

  Prof Patrick Johnston of Queen’s University Belfast & Almac Diagnostic Services honoured by President McAleese

• May 23, 2007

  Almac Clinical Technologies speaks on ‘Quality’ at 43rd DIA Annual Meeting

• May 17, 2007

  Latest iTrial EDC includes new PDF Audit Trail function

• April 30, 2007

  Almac Launches New Innovative Clinical Supply Systems

• April 27, 2007

  Almac Hosts Successful Clinical Supply Management Workshops across North America

• April 19, 2007

  `Increase Role of Science in Schools’ says Almac Chairman

• April 16, 2007

  Almac Diagnostic Services Announces Pioneering Genetic Research

• March 16, 2007

  Sir Allen McClay: “Almac Leading The Way In Global Pharmaceutical Development”

• March 9, 2007

  Almac Sciences Feature in “What Job Do You Do?”

• March 9, 2007

  Almac Clinical Technologies At Top Clinical Trial Conferences

• March 8, 2007

  Almac Sciences Invest In Edinburgh Facility

• March 5, 2007

  Almac visit QUB to brief Pharmacists

• February 14, 2007

  SafeBridge® Certification for Almac Sciences’ cytotoxics plant

• February 14, 2007

  Almac Sciences and BioCatalytics Inc. to co-operate on key pharma products

• February 14, 2007

  CPST fill-and-finish agreement for Almac Sciences’ cytotoxics

• January 29, 2007

  Almac Clinical Technologies Appoints New Director of Business Development

• January 22, 2007

  Almac distribution network now worldwide

• December 29, 2006

  Almac Recruits Additional 250 Employees in NI in 2006

• December 20, 2006

  Almac Clinical Technologies Spreading Holiday Cheer

• December 19, 2006

  Diagnostic Services Multi Year License Agreement With GeneGo

• December 18, 2006

  Almac Scoops Top UK Training Award

• December 18, 2006

  Clinical Technologies Expands Its European Operations

• December 5, 2006

  Almac Clinical Services Celebrates 10 Years in US

• November 10, 2006

  Almac Pharma Services Extend Formulation Facilities

• October 26, 2006

  Almac Hosts Science Development Day for Colleges

• October 18, 2006

  Almac Clinical Services Scoops National Training Award

• October 10, 2006

  Almac Sciences Scales Up for Peptides

• September 29, 2006

  Almac Staff Raise Funds For Northern Ireland Charities

• September 5, 2006

  Almac Clinical Technologies Celebrates Successful Launch of Drug Reconciliation Tool

• August 17, 2006

  Clinical Services Continues Expansion with New Refrigerated Facility

• August 10, 2006

  Clinical Services Expands Its Global Depot Network

• June 19, 2006

  Pharma Companies Combine Under Almac Banner

• May 22, 2006

  CTS Awarded Best Classroom Training Manual at 2006 PDA Biennial Training Conference

• May 22, 2006

  ICTI Announces New President

• May 4, 2006

  CTS Durham Undergoes EU-GMP Inspection From MHRA

• April 25, 2006

  ICTI to Speak on Adaptive Trial Design at Brussels Conference

• April 25, 2006

  CTS Host Successful Global Clinical Trial Distribution Workshops In The US

• March 28, 2006

  Health Minister Visits Almac Sciences Facility

• March 27, 2006

  ICTI Presents at DIAs 21st Clinical Data Management Symposium

• March 22, 2006

  ICTI Implements Latest Version of MasterControl Training

• March 21, 2006

  Almac Helps Governor Take Temperature Of NI Economy

• March 20, 2006

  World Renown Cancer Specialists Visit Almac Sciences

• March 20, 2006

  PDMS Extend Formulation Development Facility

• March 9, 2006

  Eirx Therapeutic Plc & Diagnostic Services Agreement

• February 16, 2006

  CSS Radio Goes Live; Chiral Building Blocks Range Announced

• February 13, 2006

  Sir Allen McClay Opens New £1.25 million Laboratory of Biology Chemistry at Queens

• February 3, 2006

  CTS Announce Agenda for Clinical Trial Distribution Workshops

• January 24, 2006

  ICTI Biostatistics Expert speaks at International Conference

• January 11, 2006

  Almac Diagnostic Services Receives ISO17025 Accreditation

• January 10, 2006

  ICTI Expands European Operations

• January 10, 2006

  ArraDx Joins Almac Sciences – Now Almac Diagnostic Services

• January 9, 2006

  Dr Allen McClay, CBE Receives Knighthood in New Year’s Honours List

• December 23, 2005

  ICTI Completes Implementation of Tech-Support Software: IncidentMonitor TM

• November 29, 2005

  CSS Focuses on Australian Market

• November 25, 2005

  CSS Launches Global Provision of Radiolabelling Services

• September 21, 2005

  ICTI software used in major Government Study

• September 14, 2005

  ICTI Expert Hosts Roundtable at FDA Conference

• July 19, 2005

  ICTI Biostatistics Expert speaks at International Conference

• June 23, 2005

  ICTI Increase Drug Study Management Efficiency

• May 9, 2005

  PDMS Awards Major Pharmaceuticals Manufacturing System Contract to SSI

• May 5, 2005

  ICTI Announce Successful Implementation of a SAN

• April 21, 2005

  ICTI Marks Milestone for EDC

• March 9, 2005

  ICTI Acquires Leading EDC Software

• March 4, 2005

  CSS Albachem Secures a Share of £3.7 million R&D Programme

• December 21, 2004

  Chiral Consortium

• December 7, 2004

  CSS Enters Chiral Market Through Collaborations with ChiralQuest and IEP

• December 7, 2004

  CSS Expands Capability in Specialist Manufacturing

• October 28, 2004

  CSS Launches Unique Consortium at CPhI

• August 23, 2004

  Company Name Change

• May 10, 2004

  CSS Acquires Controlling Interest in Peptide Company ALBACHEM

• December 2, 2003

  Almac Sciences acquire PDMS

• September 1, 2003

  Senator GEORGE MITCHELL Officially Opens New CSS Facility